Eggs May Aid Weight Maintenance After Wegovy, Study Suggests
Nutrition experts suggest eggs could be a key food for managing appetite and preventing weight regain for those stopping GLP-1 weight-loss injections like Wegovy and Mounjaro.
Category : Search result: Wegovy UK
Wegovy Pill Launched in US, UK Decision Expected
Novo Nordisk launches daily Wegovy weight-loss pill in the US. The UK regulator could approve it this year, offering a needle-free alternative. Discover the pricing and market impact.
Wegovy Weight Loss Pills Go On Sale in US
Novo Nordisk launches Wegovy weight loss pills in the US from January 5, priced from $149 per month. The FDA-approved oral medication offers injectable-like efficacy for obesity treatment.
M&S Targets Weight Loss Drug Users with New Food Line
Marks & Spencer unveils a 20-product 'nutrient dense' range for customers on GLP-1 weight loss drugs. Launching January 5, it addresses reduced appetite and fibre gaps. Discover the details.
Weight Loss Jabs Could Slow Prostate Cancer Spread
UK researchers believe drugs like Wegovy may disrupt fat-cancer communication, slowing disease progression and improving treatment response. Could this be a new weapon against the UK's most common male cancer?
Wegovy Daily Pill Approved in US, UK Plans for 2026
A daily pill version of the weight-loss drug Wegovy has been approved in the US, with its maker Novo Nordisk planning a UK regulatory submission in 2026. The oral treatment offers an alternative to injections.
US Approves First Daily Obesity Pill: Wegovy Oral
The US FDA has approved a daily pill version of Wegovy, marking a major shift in obesity treatment. This oral medication could expand access and lower costs for millions.
6 Christmas foods to avoid on Ozempic or Wegovy
An NHS GP reveals the festive treats that could trigger nausea and bloating for users of Ozempic, Wegovy and Mounjaro, offering safer alternatives for the holidays.
Weight Watchers launches new programme for weight-loss jab users
Weight Watchers unveils a new GLP-1 Success Programme for people using medications like Ozempic. Launching in January 2026, it offers coaching and nutritional support. Read more.
Semaglutide Reduces Epilepsy Risk in Diabetes Patients
A major study reveals GLP-1 drugs like Ozempic and Wegovy may protect brain health, slashing epilepsy risk for millions with type 2 diabetes. Discover the neurological benefits.
Christmas Drink Warning for GLP-1 Weight Loss Patients
Medical experts issue festive warning to users of weight-loss jabs like Wegovy and Mounjaro, urging them to avoid a top UK festive tipple to prevent severe side effects. Learn which drinks are safe.
Diabetes drugs Ozempic, Wegovy tied to chronic cough risk
A major study finds GLP-1 drugs like Ozempic increase chronic cough risk by up to 25% in type 2 diabetes patients. Discover the surprising findings and potential mechanisms behind this side effect.
WHO: Weight Loss Jab Shortage as Obesity to Double
The World Health Organization warns of critical shortages in GLP-1 weight loss drugs like Wegovy, with fewer than 10% who need them able to access treatment. Urgent action is needed to prevent obesity rates from soaring.
WHO: Weight Loss Jab Shortage as Obesity to Double
The World Health Organization warns fewer than 10% who need obesity drugs like Wegovy can access them. With costs soaring and supply limited, urgent action is needed to prevent a global health crisis.
Savile Row tailors struggle with weight loss jabs
Savile Row tailors face a new challenge as clients on weight loss drugs like Ozempic rapidly change shape, requiring entire suits to be remade. Discover the impact on bespoke tailoring.
52 UK deaths linked to weight loss jabs
Exclusive: Dozens of deaths in Britain have been linked to blockbuster weight loss injections like Ozempic and Mounjaro. Experts sound the alarm over inappropriate use.
WeightWatchers to Sell Wegovy Weight-Loss Pill
WeightWatchers announces plans to sell Novo Nordisk's Wegovy in pill form, a strategic move following its bankruptcy. Discover how this impacts the competitive weight-loss drug market.
Trump slams 'fat shot' weight loss drugs in explosive rant
Donald Trump launches astonishing attack on revolutionary weight-loss injections like Wegovy and Ozempic, branding them the 'fat shot' while claiming natural methods are superior. The former president's controversial health comments spark medical debate.
Trump's plan to slash weight-loss drug prices
Former President Donald Trump proposes dramatic government intervention to cut costs of blockbuster drugs like Ozempic and Wegovy, challenging pharmaceutical giants and reshaping US healthcare policy.
Trump pledges to cut weight-loss drug prices
Former President Donald Trump vows to dramatically reduce prices of GLP-1 medications including Ozempic and Wegovy if re-elected, targeting pharmaceutical giants in latest healthcare pledge.
Weight Loss Drug Showdown: Novo Nordisk vs Eli Lilly
The pharmaceutical weight loss market heats up as Novo Nordisk's blockbuster drugs Wegovy and Ozempic confront serious competition from Eli Lilly's Mounjaro, reshaping diabetes and obesity treatment landscapes.
Novo Nordisk cuts forecasts again amid drug competition
Danish pharmaceutical giant Novo Nordisk cuts sales and profit forecasts for second time amid intensifying competition in weight-loss drug market.
Trump's Secret Stance on Weight Loss Drugs Exposed
Explosive revelations emerge about Donald Trump's private stance on revolutionary weight loss drugs while new research highlights their massive economic potential.
US Obesity Rates Hit Record High Amid New Drug Hope
New CDC data reveals American obesity rates have hit unprecedented levels, while revolutionary GLP-1 medications like Wegovy and Zepbound show promising results in combating the epidemic.
Wegovy's hidden mental benefits revealed
Stanford psychologist reveals how weight-loss drugs like Wegovy create profound mental changes that could revolutionise obesity treatment beyond mere physical transformation.
Gyms cash in on weight-loss jab muscle crisis
As slimming injections surge in popularity, fitness centres report booming business from users fighting to preserve muscle mass while shedding pounds
Weight Loss Injections Cut Heart Attack Risk
Groundbreaking research shows popular weight loss medications like Wegovy and Ozempic dramatically reduce cardiovascular events, offering dual protection for patients.
Academics Urge Lower BMI for Wegovy Access
University College London researchers call for expanding Wegovy access after revealing compelling new evidence that could change NHS obesity treatment guidelines.
Weight loss jabs boost heart health, study finds
Groundbreaking research shows popular weight loss injections like Wegovy and Ozempic significantly reduce cardiovascular risks alongside promoting weight loss, offering new hope for millions.
Weight loss jabs slash heart risk in UK study
Groundbreaking research reveals popular weight loss injections Wegovy and Ozempic significantly reduce heart attack and stroke risks, offering dual benefits for millions struggling with obesity.
Page 1 of 4